$4.62 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 30 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 41.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $416,549,000 | +8.8% | 2,415,686 | -18.3% | 9.01% | +26.3% |
BIDU | Sell | BAIDU INCspon adr rep a | $300,830,000 | -8.7% | 1,443,520 | -0.1% | 6.51% | +6.0% |
INFA | Sell | INFORMATICA CORP | $255,668,000 | +3.8% | 5,829,847 | -9.7% | 5.53% | +20.5% |
ALR | Sell | ALERE INC | $253,219,000 | +23.3% | 5,178,302 | -4.2% | 5.48% | +43.2% |
MLNX | Sell | MELLANOX TECHNOLOGIES LTD | $142,187,000 | -22.3% | 3,136,006 | -26.7% | 3.08% | -9.7% |
SPY | Sell | SPDR S&P 500 ETF TRput | $122,124,000 | -79.0% | 591,600 | -79.1% | 2.64% | -75.7% |
IWM | Sell | ISHARES TRput | $118,612,000 | -79.8% | 953,700 | -80.5% | 2.56% | -76.5% |
DAR | Sell | DARLING INGREDIENTS INC | $62,920,000 | -57.2% | 4,491,055 | -44.5% | 1.36% | -50.3% |
BA | Sell | BOEING COput | $45,249,000 | -49.2% | 301,500 | -56.0% | 0.98% | -41.0% |
PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $37,227,000 | +27.5% | 980,700 | -4.9% | 0.80% | +48.0% |
PHH | Exit | PHH CORP | $0 | – | -145,400 | -100.0% | -0.06% | – |
TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -402,800 | -100.0% | -0.43% | – |
USO | Exit | UNITED STATES OIL FUND LPunits | $0 | – | -1,794,852 | -100.0% | -0.68% | – |
COH | Exit | COACH INCcall | $0 | – | -2,476,600 | -100.0% | -1.73% | – |
MSI | Exit | MOTOROLA SOLUTIONS INCput | $0 | – | -1,500,100 | -100.0% | -1.87% | – |
AN | Exit | AUTONATION INC | $0 | – | -2,301,239 | -100.0% | -2.59% | – |
TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -3,333,717 | -100.0% | -3.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
ISHARES TR | 28 | Q3 2023 | 10.9% |
MANNKIND CORP | 24 | Q3 2023 | 0.5% |
BAIDU INC | 21 | Q2 2018 | 8.6% |
ITRON INC | 21 | Q3 2020 | 12.1% |
RETROPHIN INC | 20 | Q3 2020 | 4.5% |
HARMONIC INC | 19 | Q3 2023 | 10.5% |
JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SC 13D | 2024-04-26 |
13F-HR | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13D/A | 2024-01-22 |
13F-HR/A | 2023-11-14 |
13F-HR | 2023-11-14 |
SC 13D | 2023-09-21 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.